相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread
Ping-Pui Wong et al.
CANCER CELL (2015)
901a A Randomized, Multicenter Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in Patients With Moderate to Severe Ulcerative Colitis: Results of the TURANDOT Study
Walter Reinisch et al.
GASTROENTEROLOGY (2015)
Leukocyte integrins: Role in leukocyte recruitment and as therapeutic targets in inflammatory disease
Ioannis Mitroulis et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Novel antiplatelet agents in acute coronary syndrome
Francesco Franchi et al.
NATURE REVIEWS CARDIOLOGY (2015)
The Immunological Synapse: A Molecular Machine Controlling T Cell Activation
Arash Grakoui et al.
JOURNAL OF IMMUNOLOGY (2015)
Targeting Integrin and Integrin Signaling in Treating Thrombosis
Brian Estevez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
RUC-4 A Novel αIIbβ3 Antagonist for Prehospital Therapy of Myocardial Infarction
Jihong Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases
Wei-Jian Pan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Effects of Vedolizumab Induction Therapy for Patients With Crohn's Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
Bruce E. Sands et al.
GASTROENTEROLOGY (2014)
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Severine Vermeire et al.
LANCET (2014)
Cilengitide in glioblastoma: when did it fail?
Olivier L. Chinot
LANCET ONCOLOGY (2014)
Integrins: therapeutic targets in airway hyperresponsiveness and remodelling?
David B. Wright et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Pharmacology of AMG 181, a human anti-α4β7 antibody that specifically alters trafficking of gut-homing T cells
W. J. Pan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Integrin αIIbβ3 From Discovery to Efficacious Therapeutic Target
Kamila Bledzka et al.
CIRCULATION RESEARCH (2013)
The Mechanism of Kindlin-Mediated Activation of Integrin αIIbβ3
Feng Ye et al.
CURRENT BIOLOGY (2013)
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
Paul J. Rutgeerts et al.
GUT (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation
Craig T. Lefort et al.
BLOOD (2012)
Vedolizumab for the treatment of active ulcerative colitis: A randomized controlled phase 2 dose-ranging study
Asit Parikh et al.
INFLAMMATORY BOWEL DISEASES (2012)
Contemporary use of glycoprotein IIb/IIIa inhibitors
Steen Dalby Kristensen et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Integrins as therapeutic targets
Simon L. Goodman et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
E. G. Stefanich et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Discovery of Very Late Antigen-4 (VLA-4, α4β1 Integrin) Allosteric Antagonists
Alexandre Chigaev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Real-time Analysis of the Inside-out Regulation of Lymphocyte Function-associated Antigen-1 Revealed Similarities to and Differences from Very Late Antigen-4
Alexandre Chigaev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Rolling on E- or P-selectin induces the extended but not high-affinity conformation of LFA-1 in neutrophils
Yoshihiro Kuwano et al.
BLOOD (2010)
Structure of an integrin with an αI domain, complement receptor type 4
Can Xie et al.
EMBO JOURNAL (2010)
Dynamic T cell migration program provides resident memory within intestinal epithelium
David Masopust et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Neurological infections: the year of PML and influenza
Joseph R. Berger et al.
LANCET NEUROLOGY (2010)
The final steps of integrin activation: the end game
Sanford J. Shattil et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
The SYK tyrosine kinase: a crucial player in diverse biological functions
Attila Mocsai et al.
NATURE REVIEWS IMMUNOLOGY (2010)
LAD-1/variant syndrome is caused by mutations in FERMT3
Taco W. Kuijpers et al.
BLOOD (2009)
Pharmacological characterization of PF-00547659, an anti-human MAdCAM monoclonal antibody
N. Pullen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Functional Role of CD11c+ Monocytes in Atherogenesis Associated With Hypercholesterolemia
Huaizhu Wu et al.
CIRCULATION (2009)
S1066 Oral Alpha-4 Integrin Inhibitor (AJM300) in Patients with Active Crohn's Disease — A Randomized, Double-Blind, Placebo-Controlled Trial
Masakazu Takazoe et al.
GASTROENTEROLOGY (2009)
Monoclonal anti body-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
Kenneth R. Carson et al.
LANCET ONCOLOGY (2009)
Kindlin-3 is required for β2 integrin-mediated leukocyte adhesion to endothelial cells
Markus Moser et al.
NATURE MEDICINE (2009)
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
Andrew R. Reynolds et al.
NATURE MEDICINE (2009)
The Tail of Integrins, Talin, and Kindlins
Markus Moser et al.
SCIENCE (2009)
The GPIIb/IIIa (integrin αIIbβ3) odyssey:: a technology-driven saga of a receptor with twists, turns, and even a bend
Barry S. Coller et al.
BLOOD (2008)
Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
Brian G. Feagan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Health-related quality of life in multiple sclerosis - Current evidence, measurement and effects of disease severity and treatment
Richard A. Rudick et al.
CNS DRUGS (2008)
A nonsynonymous functional variant in integrin-αM (encoded by ITGAM) is associated with systemic lupus erythematosus
Swapan K. Nath et al.
NATURE GENETICS (2008)
Kindlin-3 is essential for integrin activation and platelet aggregation
Markus Moser et al.
NATURE MEDICINE (2008)
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
M. Krumbholz et al.
NEUROLOGY (2008)
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX
Geoffrey Hom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The incidence and significance of anti-natalizumab antibodies -: Results from AFFIRM and SENTINEL
P. A. Calabresi et al.
NEUROLOGY (2007)
Health-related quality of life in multiple sclerosis: Effects of Natalizumab
Richard A. Rudick et al.
ANNALS OF NEUROLOGY (2007)
Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid
Daniel Mucida et al.
SCIENCE (2007)
Natalizumab for the treatment of active Crohn's disease: Results of the ENCORE trial
Stephan R. Targan et al.
GASTROENTEROLOGY (2007)
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
D. H. Miller et al.
NEUROLOGY (2007)
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
L. J. Balcer et al.
NEUROLOGY (2007)
A mechanistic model for paradoxical platelet activation by ligand-mimetic αIIbβ3 (GPIIb/IIIa) antagonists
Nicole Bassler et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Spleen tyrosine kinase syk is necessary for E-Selectin-induced alpha(L)beta 2 integrin-mediated rolling on intercellular adhesion molecule-1
Alexander Zarbock et al.
IMMUNITY (2007)
Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs
Attila Mocsai et al.
NATURE IMMUNOLOGY (2006)
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment -: The ISAR-REACT 2 randomized trial
A Kastrati et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease
DH Adams et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Natalizumab induction and maintenance therapy for Crohn's disease
WJ Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin
BG Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Targeting leukocyte integrins in human diseases
K Yonekawa et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors
RH Aster
CHEST (2005)
Rolling adhesion through an extended conformation of integrin αLβ2 and relation to α I and β I-like domain interaction
A Salas et al.
IMMUNITY (2004)
Retinoic acid imprints gut-homing specificity on T cells
M Iwata et al.
IMMUNITY (2004)
Integrin β3 regions controlling binding of murine mAb 7E3:: Implications for the mechanism of integrin αIIbβ3 activation
A Artoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy
RA Du Pasquier et al.
BRAIN (2004)
Oral GPIIb/IIIa antagonists: What went wrong?
D Cox
CURRENT PHARMACEUTICAL DESIGN (2004)
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics
T Xiao et al.
NATURE (2004)
Src kinase activation by direct interaction with the integrin β cytoplasmic domain
EG Arias-Salgado et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Talin binding to integrin β tails:: A final common step in integrin activation
S Tadokoro et al.
SCIENCE (2003)
Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins
M Kim et al.
SCIENCE (2003)
Small molecule integrin antagonists that bind to the β2 subunit I-like domain and activate signals in one direction and block them in the other
M Shimaoka et al.
IMMUNITY (2003)
Therapeutic antagonists and conformational regulation of integrin function
M Shimaoka et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Platelet-collagen interaction: is GPVI the central receptor?
B Nieswandt et al.
BLOOD (2003)
Structures of the αL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation
M Shimaoka et al.
CELL (2003)
Natalizumab for active Crohn's disease.
S Ghosh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling
J Takagi et al.
CELL (2002)
Syk is required for integrin signaling in neutrophils
A Mócsai et al.
IMMUNITY (2002)
A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin
FH Gordon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Use of anti-ICAM-1 therapy in ischemic stroke -: Results of the Enlimomab Acute Stroke Trial
DG Sherman et al.
NEUROLOGY (2001)
The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and α4 integrin in the inflammatory response of neutrophils
RB Henderson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
G Weitz-Schmidt et al.
NATURE MEDICINE (2001)
MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)
AJ Grant et al.
HEPATOLOGY (2001)
Effects of abciximab and tirofiban on vitronectin receptors in human endothelial and smooth muscle cells
U Kintscher et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
An ascending dose trial of a humanized A4B7 antibody in ulcerative colitis (UC).
BG Feagan et al.
GASTROENTEROLOGY (2000)
分享论文
